Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04695665
Other study ID # Vlasák, McGill
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 15, 2020
Est. completion date May 30, 2020

Study information

Verified date January 2021
Source Charles University, Czech Republic
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this study is to determine the applicability of McGill ́s method to patients with diagnoses, collectively referred to as Vertebrogenic Algic syndrome, by comparing the measured data of proband with different diagnosis locations Vertebrogenic Algic syndrome in the Czech Republic.


Description:

This is a pilot experimental research involving 10 probands diagnosed with Vertebrogenic Algic syndrome in the cervical spine, 10 probands diagnosed with Vertebrogenic Algic syndrome in the thoracic spine and 10 probands diagnosed with Vertebrogenic Algic syndrome in the lumbar spine. Each participant undergo a kinesiological examination according to the McGill ́s principles together with an SF-36 questionnaire. Measured values are compared and provided a basis for testing the hypotheses. The study uses methods of research, observation, querying and comparison of collected data.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date May 30, 2020
Est. primary completion date March 15, 2020
Accepts healthy volunteers No
Gender All
Age group 20 Years to 55 Years
Eligibility Inclusion Criteria: - cervical pain syndrome - thoracic pain syndrome - lumbar pain syndrome Exclusion Criteria: - red falgs

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Cervical pain
Exercise program for cervical spine according to McGill's approach.
Thoracic pain
Exercise program for thoracic spine according to McGill's approach.
Lumbar pain
Exercise program for lumbar spine according to McGill's approach.

Locations

Country Name City State
Czechia Charles University, Faculty of physical education and sport Praha

Sponsors (1)

Lead Sponsor Collaborator
Charles University, Czech Republic

Country where clinical trial is conducted

Czechia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pain relief change in pain perception measured on a visual analog scale - from 0 (without pain) to 10 (maximum pain) 4 weeks, 2 times a week exercising for 60 minutes
Primary multi-segmental efficiency comparison of the effectiveness of therapy of the three evaluated groups against each other by Short Form (SF36) Healthy survey questionnaire, the scale from 100 to 900, lower value indicate a higher effect 4 weeks